Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma

Beijing Cancer Hospital, Beijing

The First Hospital of Jilin University, Changchun

Harbin Medical University Cancer Hospital, Harbin

Fudan University Shanghai Cancer Center, Shanghai

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou

Institute of Hematology and Hospital of Blood Disease, Tianjin

Tianjin Medical University Cancer Institute and Hospital, Tianjin

Zhejiang Cancer Hospital, Hangzhou

Henan Cancer Hospital, Zhengzhou

West China Hospital, Sichuan University, Chengdu